Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
21.27
-0.71 (-3.23%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Castle Biosciences Employees
Castle Biosciences had 761 employees as of December 31, 2024. The number of employees increased by 151 or 24.75% compared to the previous year.
Employees
761
Change (1Y)
151
Growth (1Y)
24.75%
Revenue / Employee
$436,359
Profits / Employee
$23,975
Market Cap
613.53M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
CSTL News
- 16 days ago - Castle Biosciences Strengthens Commitment to Esophageal Cancer Awareness Through Collaborative Partnerships - GlobeNewsWire
- 17 days ago - Castle Biosciences Honored with a Top Workplaces USA Award for Fourth Consecutive Year - GlobeNewsWire
- 21 days ago - Publication of Data from Prospective, Multicenter Study Demonstrates Positive Survival Outcomes in Patients with Low-Risk Melanoma Who Avoided Sentinel Lymph Node Biopsy with Information from Castle Biosciences' DecisionDx®-Melanoma Test - GlobeNewsWire
- 22 days ago - Castle Biosciences to Present New Data at EADO Supporting the Clinical Value of the DecisionDx®-Melanoma Test in Guiding Risk-Aligned Management of Patients with Melanoma - GlobeNewsWire
- 26 days ago - Castle Biosciences' DecisionDx®-SCC Data Earns Top Five Abstract at NCCN 2025, Shows Significantly Enhanced Risk Stratification Beyond Current Staging Within NCCN Risk Groups - GlobeNewsWire
- 6 weeks ago - New Data to be Presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting Further Strengthens Evidence Supporting the Clinical Value of Castle Biosciences' Dermatology Portfolio - Business Wire
- 7 weeks ago - Castle Biosciences, Inc. (CSTL) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Castle Biosciences Reports Fourth Quarter and Full-Year 2024 Results - Business Wire